ArticleJournal of periodontology2026
Porphyromonas gingivalis and Scardovia wiggsiae promote neutrophil-induced lung epithelial cell apoptosis and emphysema.
Article in Journal of periodontology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
backgroundChronic obstructive pulmonary disease (COPD) is a chronic lung disease with bronchitis and pulmonary emphysema phenotypes, with high morbidity and mortality. COPD is predicted to be the third leading cause of death by 2030. Periodontitis results from oral microbe dysbiosis, such as enrichment of periodontitis pathogens (e.g., Porphyromonas gingivalis), which could disseminate to the lung via the blood stream or aspiration. Periodontitis pathogens are suggested to contribute to chronic inflammation and mucin secretion in the lung. Accordingly, periodontitis pathogens are associated with the pathogenesis and progression of COPD. However, clinical observation of a correlation between COPD and periodontitis is limited and the involved mechanism is not fully understood.
methodsWe used a mouse model with ligature-induced periodontitis and porcine pancreatic elastase (PPE)-induced pulmonary emphysema to evaluate the roles of P. gingivalis and Scardovia wiggsiae in COPD progression. We analyzed proinflammatory cytokines, immune cells, apoptosis, and the extent of COPD progression using a multiplex assay/enzyme-linked immunosorbent assay, Hemacolor kit, terminal deoxynucleotidyl transferase nick-end labeling assay, and the mean linear intercept and lung function, respectively.
resultsThe results suggest that both oral bacterial species contributed to the periodontitis phenotype, promoted PPE-induced proinflammatory cytokines in serum and bronchoalveolar lavage, and facilitated neutrophil infiltration in the lung. The abundance of neutrophils increased neutrophil elastase (NE) and downstream placenta growth factor (PGF) in the lung and led to alveolar epithelial cell apoptosis, pulmonary emphysema and lung function decline in the PPE-treated mice. All pathological phenotype were attenuated by Ly6G antibody-mediated neutrophil depletion in mice.
conclusionsWe demonstrated a potential mechanism for periodontal-associated progression to COPD via the neutrophil-NE-PGF pathway. PLAIN LANGUAGE SUMMARY: We demonstrated that the oral bacteria Porphyromonas gingivalis and Scardovia wiggsiae exacerbate ligature-induced inflammation and increase proinflammatory cytokines in local gingival crevicular fluid, systemic serum, and distal bronchoalveolar lavage, and are associated with more neutrophil infiltration in the lung. The in vivo experiment indicated that gingival infection with P. gingivalis and S. wiggsiae worsens porcine pancreatic elastase-induced pulmonary apoptosis and emphysema. Here, we show that P. gingivalis and S. wiggsiae are potential pathogenic factors for COPD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.